[ad_1]
Aevice Well being has introduced that its flagship medical gadget, a wearable stethoscope for respiratory well being monitoring, has been accredited by Singapore’s Well being Sciences Authority.
The AI-powered wearable stethoscope AeviceMD, which is worn on the chest, repeatedly detects and data irregular breath sounds, similar to wheezing, and displays important indicators together with coronary heart charge and respiratory charge.
Primarily based on a press assertion, the monitoring gadget system has been accredited to be used in individuals aged three and above and in each medical and residential settings.
WHY IT MATTERS
Singapore has one of many highest bronchial asthma and COPD prevalences on the planet. Bronchial asthma impacts round 5% of adults and 20% of kids within the nation whereas COPD is likely one of the 10 main illness killers.
With its distant well being monitoring know-how, Aevice Well being goals to assist scale back ED shows and readmissions amongst sufferers coping with these power respiratory illnesses. By offering well being professionals with an summary of a affected person’s lung well being, AeviceMD helps the early detection of potential exacerbations.
In response to the corporate, it can use its HSA approval as a springboard to develop the attain of its know-how to populations with excessive instances of respiratory illnesses.
“We’re excited to leverage Singapore’s strategic presence in Asia as a medical hub to carry this novel know-how into new markets the place there’s a excessive prevalence of respiratory illnesses,” Aevice Well being CEO Adrian Ang shared.
THE LARGER TREND
The market approval comes two years since Aevice Well being first performed a clinical trial of AeviceMD with the Nationwide College Well being System to research its use instances in paediatric sufferers with respiratory difficulties.
Other than Singapore, the gadget has additionally been introduced in Japan utilizing the $2 million proceeds from its pre-Sequence A funding spherical in 2021.
[ad_2]
